← brief for 2026-11-03 · Slowing decline

Efficacy and influencing factors of rituximab in idiopathic membranous nephropathy : A real-world retrospective study

Article No results yet Peer reviewed

Key takeaways

Who did this work

Xu X (Department of Nephrology, The First People’s Hospital of Xiaoshan District, Hangzhou, Zhejiang Province, China) · Zhou Q (Medical Device Inspection Section, Zhejiang Center for Drug Inspection, Hangzhou, Zhejiang Province, China.) · Li S (Department of Nephrology, The First People’s Hospital of Xiaoshan District, Hangzhou, Zhejiang Province, China) · Zhang X (Department of Nephrology, The First People’s Hospital of Xiaoshan District, Hangzhou, Zhejiang Province, China) · Zhang X (Department of Nephrology, The First People’s Hospital of Xiaoshan District, Hangzhou, Zhejiang Province, China)

Source

Article · Europe PMC, CKD · 2026-10-30
https://europepmc.org/article/PMC/PMC13727179